Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-002654
Filing Date
2018-04-09
Accepted
2018-04-09 17:08:19
Documents
95
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2235058z10-k.htm 10-K 2142796
2 EX-3.2 a2235058zex-3_2.htm EX-3.2 11246
3 EX-10.89 a2235058zex-10_89.htm EX-10.89 81157
4 EX-23.1 a2235058zex-23_1.htm EX-23.1 3154
5 EX-31.1 a2235058zex-31_1.htm EX-31.1 8390
6 EX-31.2 a2235058zex-31_2.htm EX-31.2 8381
7 EX-32.1 a2235058zex-32_1.htm EX-32.1 4659
8 EX-32.2 a2235058zex-32_2.htm EX-32.2 4649
15 G557747.JPG g557747.jpg GRAPHIC 71681
16 G11124KI01I001.JPG g11124ki01i001.jpg GRAPHIC 3182
17 G11124KI01I002.GIF g11124ki01i002.gif GRAPHIC 721
  Complete submission text file 0001047469-18-002654.txt   14246176

Data Files

Seq Description Document Type Size
9 EX-101.INS jagx-20171231.xml EX-101.INS 3594783
10 EX-101.SCH jagx-20171231.xsd EX-101.SCH 118441
11 EX-101.CAL jagx-20171231_cal.xml EX-101.CAL 103375
12 EX-101.DEF jagx-20171231_def.xml EX-101.DEF 510284
13 EX-101.LAB jagx-20171231_lab.xml EX-101.LAB 932652
14 EX-101.PRE jagx-20171231_pre.xml EX-101.PRE 747596
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 18746231
SIC: 2834 Pharmaceutical Preparations